X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9410) 9410
Magazine Article (13) 13
Book Chapter (6) 6
Book Review (2) 2
Publication (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9150) 9150
female (5729) 5729
oncology (5253) 5253
antineoplastic combined chemotherapy protocols - therapeutic use (5045) 5045
middle aged (4817) 4817
taxoids - administration & dosage (4614) 4614
aged (4372) 4372
male (4371) 4371
docetaxel (4184) 4184
chemotherapy (3559) 3559
adult (3449) 3449
taxoids - therapeutic use (3307) 3307
treatment outcome (2673) 2673
breast neoplasms - drug therapy (2626) 2626
cancer (2574) 2574
antineoplastic agents - therapeutic use (2010) 2010
antineoplastic combined chemotherapy protocols - adverse effects (1667) 1667
paclitaxel (1631) 1631
taxoids (1557) 1557
taxoids - adverse effects (1548) 1548
breast cancer (1480) 1480
breast neoplasms - pathology (1473) 1473
lung neoplasms - drug therapy (1431) 1431
cisplatin - administration & dosage (1392) 1392
neoplasm staging (1341) 1341
disease-free survival (1303) 1303
paclitaxel - analogs & derivatives (1298) 1298
paclitaxel - administration & dosage (1234) 1234
aged, 80 and over (1227) 1227
carcinoma, non-small-cell lung - drug therapy (1172) 1172
pharmacology & pharmacy (1158) 1158
care and treatment (1140) 1140
cisplatin (1117) 1117
deoxycytidine - analogs & derivatives (1105) 1105
drug administration schedule (1102) 1102
animals (1097) 1097
therapy (1092) 1092
antineoplastic agents, phytogenic - therapeutic use (1056) 1056
prostatic neoplasms - drug therapy (1039) 1039
survival rate (1017) 1017
fluorouracil - administration & dosage (1016) 1016
prognosis (1004) 1004
trial (987) 987
medicine & public health (971) 971
retrospective studies (957) 957
prostate cancer (952) 952
paclitaxel - therapeutic use (937) 937
survival (926) 926
survival analysis (890) 890
neoplasm metastasis (882) 882
deoxycytidine - administration & dosage (872) 872
taxoids - pharmacology (860) 860
chemotherapy, adjuvant (850) 850
metastasis (833) 833
research (827) 827
cell line, tumor (815) 815
carcinoma (801) 801
antineoplastic agents - administration & dosage (789) 789
neoadjuvant therapy (770) 770
drug resistance, neoplasm (766) 766
antineoplastic combined chemotherapy protocols - administration & dosage (713) 713
combined modality therapy (713) 713
mice (700) 700
hematology, oncology and palliative medicine (694) 694
antineoplastic agents (693) 693
analysis (690) 690
lung neoplasms - pathology (657) 657
doxorubicin (640) 640
phase-ii trial (628) 628
adenocarcinoma - drug therapy (626) 626
antimitotic agents (624) 624
drug therapy (620) 620
disease progression (615) 615
dose-response relationship, drug (608) 608
antineoplastic agents - adverse effects (606) 606
combination (599) 599
stomach neoplasms - drug therapy (570) 570
follow-up studies (565) 565
antineoplastic agents - pharmacology (547) 547
prostatic neoplasms - pathology (541) 541
paclitaxel - adverse effects (538) 538
carboplatin - administration & dosage (530) 530
gemcitabine (528) 528
expression (526) 526
cyclophosphamide - administration & dosage (524) 524
antineoplastic agents, phytogenic - administration & dosage (523) 523
trastuzumab (522) 522
tumors (522) 522
carcinoma, non-small-cell lung - pathology (518) 518
kaplan-meier estimate (517) 517
cancer research (511) 511
clinical trials (507) 507
doxorubicin - administration & dosage (505) 505
phase-ii (504) 504
health aspects (500) 500
carcinoma, squamous cell - drug therapy (499) 499
clinical trials as topic (497) 497
capecitabine (485) 485
prospective studies (481) 481
radiotherapy (480) 480
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8611) 8611
Japanese (542) 542
Chinese (154) 154
French (130) 130
German (87) 87
Russian (37) 37
Italian (33) 33
Spanish (24) 24
Hungarian (18) 18
Dutch (8) 8
Korean (6) 6
Polish (5) 5
Danish (4) 4
Lithuanian (4) 4
Czech (3) 3
Portuguese (3) 3
Finnish (2) 2
Hebrew (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Croatian (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 44, pp. 61 - 73
Journal Article
European Urology, ISSN 0302-2838, 2011, Volume 61, Issue 5, pp. 950 - 960
...) progression has led to the recognition of multiple molecular targets and advances in the therapeutic landscape... 
Urology | Molecular targets | Chemotherapy | Immunotherapy | Androgen pathway inhibitors | Biologic agents | Androgen receptor | Prostate cancer | Skeletal-related events | ADVANCED SOLID TUMORS | DOCETAXEL | PATHWAY ACTIVATION | MITOXANTRONE PLUS PREDNISONE | INHIBITION | RANDOMIZED PHASE-II | CLINICAL-TRIALS | UROLOGY & NEPHROLOGY | END-POINTS | HIGH-DOSE CALCITRIOL | Receptors, Vascular Endothelial Growth Factor | Anilides - therapeutic use | Phenylthiohydantoin - therapeutic use | Humans | Ipilimumab | Recombinant Fusion Proteins - therapeutic use | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Thiazoles - therapeutic use | Abiraterone Acetate | Quinolones | Antibodies, Monoclonal, Humanized | Taxoids - therapeutic use | Cancer Vaccines - therapeutic use | Clinical Trials, Phase III as Topic | Bone Neoplasms - drug therapy | Clusterin - therapeutic use | Prostatic Neoplasms - drug therapy | Carcinoma - secondary | Pyridines - therapeutic use | Carcinoma - drug therapy | Dasatinib | Prostatic Neoplasms - pathology | Prostatic Neoplasms - surgery | Carcinoma - surgery | Treatment Outcome | Vaccines, Synthetic - therapeutic use | Tissue Extracts - therapeutic use | Denosumab | Radium - therapeutic use | Phenylthiohydantoin - analogs & derivatives | Orchiectomy | Pyrimidines - therapeutic use | Androstadienes - therapeutic use | Quinolines - therapeutic use | Medical colleges | Hospitals | Development and progression | Metastasis | Tubulins | Cancer | Landscape | Conferences | Immunoregulation | Clinical trials | Data processing | Oncology | Src protein | Clusterin | Metastases | Angiogenesis | Signal transduction | Androgens | Antagonism | Databases | Reviews | Tubulin | Acetic acid
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2015, Volume 2015, Issue 6, p. CD003366
Journal Article
Dermatologic Surgery, ISSN 1076-0512, 09/2014, Volume 40, Issue 9, pp. 948 - 963
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 25, pp. 2385 - 2394
In a prospective, randomized, phase 3 trial of crizotinib as second-line therapy in patients who had disease progression while receiving a platinum-based... 
REARRANGEMENT | MEDICINE, GENERAL & INTERNAL | GEFITINIB | ONCOLOGY | EML4-ALK FUSION GENE | CLINICAL-TRIALS | PHASE-III | LYMPHOMA | OPEN-LABEL | DOCETAXEL | EGFR | Glutamates - therapeutic use | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Glutamates - adverse effects | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Young Adult | Taxoids - therapeutic use | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Guanine - adverse effects | Guanine - therapeutic use | Taxoids - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quality of Life | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Tyrosine | Intravenous administration | Biomedical research | Lung cancer | Liver | Fatigue | Chromosome rearrangements | Cancer therapies | Patients | Lymphoma | Metastases | Ovarian cancer | Quality of life | Confidence intervals | Chemotherapy | Dyspnea | Alopecia | Platinum | Lymphomas | Respiration | Pharmaceutical industry | Protein-tyrosine kinase
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 874 - 886
Journal Article
The Journal of urology, ISSN 1527-3792, 2015, Volume 194, Issue 6, pp. 1537 - 1547
Journal Article